PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway

被引：0
|
作者：
Xiang-Rong Shu
Jing Wu
He Sun
Li-Qun Chi
Jin-Huan Wang
机构：
[1] Tianjin University,School of Pharmaceutical Science and Technology
[2] Tianjin Huanhu Hospital,undefined
[3] Haidian Maternal & Child Health Hospital,undefined
来源：
Diagnostic Pathology | / 10卷
关键词：
Cervical Cancer; Cervical Cancer Cell; Figo Stage; Cervical Cancer Patient; Caski Cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway
    Shu, Xiang-Rong
    Wu, Jing
    Sun, He
    Chi, Li-Qun
    Wang, Jin-Huan
    DIAGNOSTIC PATHOLOGY, 2015, 10
  • [2] PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEKERK-dependent pathways
    Fu, Xueqiong
    Feng, Jiarui
    Zeng, Duan
    Ding, Yu
    Yu, Changshou
    Yang, Bing
    BIOSCIENCE REPORTS, 2014, 34 : 59 - 67
  • [3] Transglutaminase 3 suppresses proliferation and cisplatin resistance of cervical cancer cells by inactivation of the PI3K/AKT pathway
    Chen, Ruipu
    Fang, Tingyu
    Liu, Na
    Shi, Xuejiao
    Wang, Junsen
    Yu, Huaping
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (04) : 2269 - 2280
  • [4] Transglutaminase 3 suppresses proliferation and cisplatin resistance of cervical cancer cells by inactivation of the PI3K/AKT pathway
    Ruipu Chen
    Tingyu Fang
    Na Liu
    Xuejiao Shi
    Junsen Wang
    Huaping Yu
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 : 2269 - 2280
  • [5] PSAT1 Upregulation Contributes to Cell Growth and Cisplatin Resistance in Cervical Cancer Cells via Regulating PI3K/AKT Signaling Pathway
    Duan, Wenxu
    Liu, Xiaomei
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2020, 50 (04): : 512 - 518
  • [6] MALAT1 promotes cisplatin resistance in cervical cancer by activating the PI3K/AKT pathway
    Wang, N.
    Hou, M-S
    Zhan, Y.
    Shen, X-B
    Xue, H-Y
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (22) : 7653 - 7659
  • [7] Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT
    Tan, Jiaxin
    You, Yu
    Xu, Tubin
    Yu, Peng
    Wu, Dingguo
    Deng, Hao
    Zhang, Yujun
    Bie, Ping
    TOXICOLOGY LETTERS, 2014, 224 (01) : 7 - 15
  • [8] Lanthanum Chloride Sensitizes Cisplatin Resistance of Ovarian Cancer Cells via PI3K/Akt Pathway
    Fang, Shanyu
    Zhang, Ping
    Chen, Xinping
    Liu, Fujun
    Wang, Fen
    FRONTIERS IN MEDICINE, 2021, 8
  • [9] DST regulates cisplatin resistance in colorectal cancer via PI3K/Akt pathway
    Yu, Jianwei
    Deng, Xueqiong
    Lin, Xueqin
    Xie, Li
    Guo, Sisi
    Lin, Xiaoliang
    Lin, Dong
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2024,
  • [10] SCARA5 PROMOTES FERROPTOSIS AND SENSITIZES CANCER CELLS TO CISPLATIN IN CERVICAL CANCER THROUGH PI3K/AKT PATHWAY
    Fan, Weimin
    Sun, Xiaofang
    JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 : 15 - 15
12345